thing pick outlook remain among best larg cap
report result morn provid financi guidanc
process thing investor pick quarter ep come
littl light account lower-than-expect tax rate said
guidanc urolift growth well rate
compani post recent year along ep rang touch
pre-cal consensu high end howev seen manag team issu
achiev beatabl initi guidanc past believ follow
similar tact continu believ deliv best top- bottom-
line growth larg cap med tech keep us construct name
piper sandler advis iwg high perform conductor inc sale
result in-lin top-lin beat bottom line report
sale cc essenti spot target urolift
standout deliv robust growth quarter gross margin
bp yoy bp target oper margin
miss target bp due heighten sg spend associ urolift
adjust ep beat target eight cent exclud benefit tax
would penni light
guidanc perhap touch achiev still compel
manag provid guidanc today constant currenc sale growth
expect rang inclus hpc deal exclud
growth rang manag commit long-
rang plan gross oper margin expect expand nice
year bp bp respect even bigger bump expect
order get long-rang plan target adjust ep rang
might caus bit constern consensu number high end
tfx rang howev exclud headwind face compani
coronaviru impact steril tax rate share count etc rang would
littl line street view said believ manag
conserv ep outlook overli concern
top-lin solid doubl digit ep growth view quit compel
takeaway call first take-away respect compani key
urolift franchis manag call growth year follow
growth like littl lower expect continu
next page
failur realiz margin expans product recal competit
global diversifi medic technolog product provid
ep estim
debt total capit
piper sandler seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
takeaway call continu although still tough comp lap
busi believ manag take typic conserv stanc outlook
combin new rep label expans dtc advertis buoy franchis
domest year estim urolift around penetr
believ rate go significantli higher come year second updat call
announc acquisit hpc manufactur engin minim invas medic
solut although sale multipl consider math
manag indic ebitda multipl attract given deal track record
give benefit doubt estim deal nickel dime accret
earn year go forward anticip broaden reach servic
provid hpc provid nice tailwind top- bottom line
complet outlook manta possibl third take-away view mayb
littl less expect revenu believ manag conserv also
expect realiz headwind coronaviru moreov
compani anticip recaptur lost revenu throughout year expect
environ improv steadili beyond
stock thought share bit earli trade morn
surpris given commentari urolift year ep guidanc reach
street high end rang howev believ manag take typic
conserv approach respect initi guidanc absent signific unforeseen
issu would surpris see upsid materi number
consequ continu recommend name rate share ow rais price
target new price target base adjust ep estim
previous ep lower multipl roll year
in-lin peer group
page
page
good expens net incom analysi gross analysi vascular inc
million except per share data
good sold
good sold
percent sale
good sold
current disclosur inform compani locat http //www pipersandl com/researchdisclosur
